CJC 1295 No DAC 5 mg/Ipamorelin 5 mg: The Ultimate Growth Hormone Synergy
Dragon Pharma introduces a groundbreaking research combination with its CJC 1295 No DAC 5 mg/Ipamorelin 5 mg blend. This powerful peptide stack is engineered to create a synergistic effect, promoting a robust and natural pulsatile release of the body’s own Growth Hormone (GH). For bodybuilders and fitness enthusiasts engaged in research, this combination represents a sophisticated approach to enhancing muscle growth, accelerating recovery, improving sleep quality, and reducing body fat, all while mimicking the body’s natural endocrine rhythms.
DRUG DESCRIPTION
Dragon Pharma’s CJC 1295 No DAC/Ipamorelin blend is supplied as a sterile, lyophilized powder in a 10 mg / 2 mL vial, containing a precise 1:1 ratio of 5 mg of each peptide. This formulation is designed for convenience and synergistic efficacy. CJC 1295 No DAC (Modified GRF 1-29) is a growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to produce GH. Its “No DAC” version has a short half-life, promoting a natural pulsatile release rather than a sustained, unnatural elevation. Ipamorelin is a growth hormone-releasing peptide (GHRP) that works by mimicking the action of ghrelin. It powerfully stimulates GH secretion without significantly affecting cortisol or prolactin levels. When combined, they create a powerful “push and pull” effect on the pituitary gland, resulting in a significant amplification of the body’s natural GH pulse.
CJC-1295 NO DAC/IPAMORELIN PROFILE
Drug Class: Research Peptide Blend
Main Active Substance: CJC-1295 & Ipamorelin (5 mg each)
Concentration: 10 mg/vial
Presentation: 2 mL Vial
Elimination Half-Life: ~30 min (CJC), ~2 hours (Ipamorelin)
Recommended Dosage: Not established (research only)
Anabolic Ratio: N/A
Androgenic Ratio: N/A
Acne: Low risk
Hepatotoxicity: None
Aromatization: No
Manufacturer: Dragon Pharma
HOW TO USE CJC-1295 NO DAC/IPAMORELIN
For research purposes, the blend is reconstituted with bacteriostatic water. Due to the short half-life of both compounds, research protocols typically involve multiple daily administrations, often 2-3 times per day. The most effective timing is on an empty stomach, preferably upon waking and before bedtime. Research cycles can extend for 12-16 weeks due to the excellent safety profile of the compounds. This blend is often researched as a foundational therapy in more complex stacks. For instance, it can be combined with Tesamorelin 5 mg for a more comprehensive GHRH approach. To directly increase IGF-1 levels, researchers may stack it with IGF-1 LR3. For those focusing on joint repair and recovery alongside muscle growth, adding TB 500 is common. During a cutting phase, it can be paired with a non-stimulant fat burner like AOD 9604 5 mg to enhance lipolysis while preserving muscle.
POSSIBLE SIDE EFFECTS
This peptide blend is generally well-tolerated in research settings due to its pulsatile, physiological action. The most common transient side effects are related to the initial increase in GH and may include mild water retention, tingling sensations in the extremities (due to nerve compression from fluid), or joint stiffness. Some subjects may experience mild lethargy after administration. A unique but harmless side effect of GHRPs like Ipamorelin is a temporary increase in hunger shortly after injection, as it activates ghrelin receptors. Unlike synthetic GH, the risk of carpal tunnel syndrome or significant insulin resistance is considerably lower with secretagogues. Allergic reactions are rare but possible with any peptide.
CONCLUSION
Dragon Pharma’s CJC 1295 No DAC/Ipamorelin blend is a premier research compound for those seeking the benefits of elevated growth hormone levels through a natural and rhythmic secretion pattern. Its synergistic design offers a powerful yet nuanced approach to body recomposition, superior recovery, and overall anti-aging effects. For the serious researcher, it provides a compelling alternative to exogenous GH, with a favorable side effect profile and the ability to work in harmony with the body’s own endocrine system. When incorporated into a disciplined research regimen, this blend can yield significant improvements in physique quality and metabolic health.
CJC-1295 NO DAC/IPAMORELIN FAQ
CJC-1295 with DAC (Drug Affinity Complex) has a long half-life of several days, creating a constant, elevated GH level. CJC-1295 No DAC has a short half-life (~30 mins), promoting a large, natural pulse of GH and is considered superior for mimicking the body’s natural rhythm.
The short half-life of both compounds necessitates frequent dosing to create multiple strong GH pulses throughout the day, which is how the body naturally produces GH. This is more effective than a single, sustained release for stimulating growth and repair. For scientific context on GH secretion, see: National Library of Medicine – Growth Hormone.
It is recommended to administer this blend on an empty stomach. Food, especially carbohydrates, can blunt the GH-releasing response of GHRPs like Ipamorelin. A minimum 30-minute fast before and after administration is standard in research protocols.
While MK-677 is an oral GH secretagogue that creates a 24-hour elevation in GH, the CJC/Ipamorelin blend creates larger, more physiological pulses. MK-677 is convenient but can cause more significant water retention and hunger. The injectable blend offers more control over the timing and quality of the GH release.
Since this blend stimulates your body’s own pituitary function and does not cause shutdown like androgens, a traditional PCT is not required. However, a gradual tapering of the dose is sometimes implemented in research to allow the hypothalamus-pituitary axis to readjust to baseline secretion levels. A general health supplement like NAD+ can be researched for cellular recovery post-cycle.